ComplianceOnline

FDA issues warning letter to Nestle USA

  • By: Admin
  • Date: December 07, 2009
  • Source: www.fda.gov
Webinar All Access Pass Subscription Abstract:

FDA issued warning letter to Nestle USA for observed violations under misleading labeling found on their Juicy Juice Products. FDA has observed that the labeling on the product is in violation of section 403(r) of the Act [21 USC 343(r)] and 21 CFR 101, 105 and 107. The labeling includes nutrient content claims which is not allowed or a food intended for use by infants and children less than 2 years of age. This is a case of misbranding of products as per FDA.

Bookmark and Share

Trending Compliance Trainings

Trial Master File and Clinical Data Management Regulated by FDA
By - Carolyn Troiano
On Demand Access Anytime
Good Documentation Practice and Record Keeping Regulations (FDA & EMA)
By - Dr. Afsaneh Motamed Khorasani
On Demand Access Anytime
GAMP Data Integrity 21 CFR Part 11 Training Course
By - Kelly Thomas
On Demand Access Anytime
NEW Reclamation Process - Fed Gov't Payments
By - Donna K Olheiser
Live February 11, 2026
Understanding and Preparing for FDA Pharmaceutical Inspections
By - Michael Ferrante
On Demand Access Anytime
How to conduct an effective BSA Audit
By - Justin Muscolino
On Demand Access Anytime
Installation and Qualification of the Packaging Lines
By - John E Lincoln
On Demand Access Anytime
Best Sellers
You Recently Viewed
    Loading